Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-21-000391
Filing Date
2021-11-10
Accepted
2021-11-10 10:34:05
Documents
27
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skin1108form10q.htm   iXBRL 10-Q 233050
2 EXHIBIT 31.1 skin1108form10qexh31_1.htm EX-31.1 8247
3 EXHIBIT 31.2 skin1108form10qexh31_2.htm EX-31.2 8266
4 EXHIBIT 32.1 skin1108form10qexh32_1.htm EX-32.1 4020
  Complete submission text file 0001554795-21-000391.txt   1050803

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE skin-20210930.xsd EX-101.SCH 7260
6 XBRL CALCULATION FILE skin-20210930_cal.xml EX-101.CAL 15880
7 XBRL DEFINITION FILE skin-20210930_def.xml EX-101.DEF 9653
8 XBRL LABEL FILE skin-20210930_lab.xml EX-101.LAB 89499
9 XBRL PRESENTATION FILE skin-20210930_pre.xml EX-101.PRE 64164
10 EXTRACTED XBRL INSTANCE DOCUMENT skin1108form10q_htm.xml XML 66018
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 211395159
SIC: 6770 Blank Checks